J. Swagzdis

发表

Low-dose in vivo pharmacokinetic and deuterium isotope effect studies of N-nitrosodimethylamine in rats.

L. Keefer, W. Garland, N. Oldfield, 1985, Cancer research.

Functional group metabolism of dopamine-2 agonists: conversion of 4-(2-di-n-propylaminoethyl)-2-(3H)-indolone to 4-(2-di-n-propylaminoethyl)-7-hydroxy-2-(3H)-indolone.

K. Straub, B. Mico, J. Swagzdis, 1986, Journal of pharmaceutical sciences.

The influence of steroids on drug metabolism in the mouse.

W. J. Novick, J. Swagzdis, C. Stohler, 1966, The Journal of pharmacology and experimental therapeutics.

Pharmacokinetics of auranofin in animals.

T. Flanagan, D. T. Walz, H. Noguchi, 1982, The Journal of rheumatology. Supplement.

SPECTROPHOTOFLUOROMETRIC DETERMINATION OF LOW CONCENTRATIONS OF AMOBARBITAL IN PLASMA.

T. Flanagan, J. Swagzdis, 1964, Analytical biochemistry.

In vivo inhibition of phenacetin oxidation by suicide substrate 1-aminobenzotriazole.

B. Mico, J. Swagzdis, D. Federowicz, 1987, Drug metabolism and disposition: the biological fate of chemicals.

Bioavailability of a modified formulation capsule containing 25 MG hydrochlorothiazide and 50 MG triamterene

J. Swagzdis, K. Putterman, W. C. Randolph, 1985 .

Inhibition of N-nitrosodimethylamine metabolism in rats by ether anesthesia.

L. Keefer, W. Garland, N. Oldfield, 1985, Cancer research.

Metabolism of diphenidol. Urinary products in humans and dogs.

G. Burghard, C. Kaiser, T. Flanagan, 1972, Journal of medicinal chemistry.

A population pharmacokinetic‐pharmacodynamic and logistic regression analysis of lotrafiban in patients

D. Mould, J. Granett, J. Aluri, 2001, Clinical pharmacology and therapeutics.

Pharmacokinetics of dopamine-2 agonists in rats and dogs.

B. Mico, J. Swagzdis, R. Demarinis, 1986, Journal of pharmaceutical sciences.

Liquid chromatographic determination of 4-(2-di-N,N-propylaminoethyl)-2-(3H)-indolone in rat, dog, and human plasma with ultraviolet detection.

B. Mico, J. Swagzdis, 1986, Journal of pharmaceutical sciences.

Determination of 4-(2-di-n-propylaminoethyl)-7-hydroxy-2-(3H)-indolone and N-[2'-hydroxy-5'-(N,N-di-n-propylaminoethylphenyl)]methane sulfonamide in plasma by high-performance liquid chromatography with electrochemical detection.

B. Mico, J. Swagzdis, R. Gifford, 1985, Journal of chromatography.

Protein binding of glycopeptide antibiotics with diverse physical-chemical properties in mouse, rat, and human serum

B. Mico, J. Swagzdis, R. Wittendorf, 1987, Journal of Pharmacokinetics and Biopharmaceutics.